Back to ELVN

Commodore Capital LP → ELVN

Commodore Capital LP ELVN Position History

Enliven Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$150.1M
Q3 2026
Peak value
$166.2M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$72.3M
Q1 2026$128.4M
Q2 2026$166.2M
Q3 2026$150.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$150.1M3.27M——
Q2 2026$166.2M3.27M——
Q1 2026$128.4M3.27M——
Q4 2025$72.3M4.69M——

Other funds holding ELVN

Other Commodore Capital LP positions

RLAY

RELAY THERAPEUTICS INC

$224.5M
RLAY

RELAY THERAPEUTICS INC

$216.6M
RLAY

RELAY THERAPEUTICS INC

$169.2M
ALKS

ALKERMES PLC

$157.2M
ALKS

ALKERMES PLC

$148.5M
RLAY

RELAY THERAPEUTICS INC

$143.8M
COGT

COGENT BIOSCIENCES INC

$118M
ALKS

ALKERMES PLC

$116.5M